Know Cancer

or
forgot password


N/A
N/A
N/A
Not Enrolling
Both
Carcinoma, Non-Small-Cell Lung

Thank you

Trial Information


Inclusion Criteria:



- Histologically confirmed locally advanced NSCLC (squamous, large cell
undifferentiated or adenocarcinoma).

- Disease limited to the thorax, adjacent mediastinum and neurovascular structures, and
supraclavicular or scalene lymph node area, as defined by the AJCC Staging System.
This includes patients with Stage IIIA and IIIB disease.

- Performance status of 0-2 by Southwest Oncology Group criteria.

- Medically inoperable patients (Stage I or II)

- Locoregional recurrent tumor following surgery will be eligible provided they meet
other eligibility criteria.

Type of Study:

Interventional

Study Design:

Masking: Open Label, Primary Purpose: Treatment

Authority:

United States: Federal Government

Study ID:

NCRR-M01RR00042-1662

NCT ID:

NCT00005666

Start Date:

Completion Date:

Related Keywords:

  • Carcinoma, Non-Small-Cell Lung
  • Diagnostic imaging
  • Carcinoma
  • Carcinoma, Non-Small-Cell Lung

Name

Location

UH B2 C490 Box 0010 E. Medical Center DriveAnn Arbor, Michigan  48109